Publicação
Downstream processing of amorphous and co-amorphous Olanzapine powder blends
| Resumo: | The work evaluates the stability of amorphous and co-amorphous olanzapine (OLZ) in tablets manufactured by direct compression. The flowability and the compressibility of amorphous and co-amorphous OLZ with saccharin (SAC) and the properties of the tablets obtained were measured and compared to those of tablets made with crystalline OLZ. The flowability of the amorphous and mostly of the co-amorphous OLZ powders decreased in comparison with the crystalline OLZ due to the higher cohesiveness of the former materials. The stability of the amorphous and co-amorphous OLZ prior to and after tableting was monitored by XRPD, FTIR, and NIR spectroscopies. Tablets presented long-lasting amorphous OLZ with enhanced water solubility, but the release rate of the drug decreased in comparison with tablets containing crystalline OLZ. In physical mixtures made of crystalline OLZ and SAC, an extent of amorphization of approximately 20% was accomplished through the application of compaction pressures and dwell times of 155 MPa and 5 min, respectively. The work highlighted the stability of amorphous and co-amorphous OLZ during tableting and the positive effect of compaction pressure on the formation of co-amorphous OLZ, providing an expedited amorphization technique, given that the process development-associated hurdles were overcome. |
|---|---|
| Autores principais: | Costa, Nuno F. da |
| Outros Autores: | Daniels, Rolf; Fernandes, Ana I.; Pinto, João F. |
| Assunto: | Olanzapine (Co-)amorphous Cohesiveness Compressibility Flowability Tablets |
| Ano: | 2022 |
| País: | Portugal |
| Tipo de documento: | artigo |
| Tipo de acesso: | acesso aberto |
| Instituição associada: | Egas Moniz - Cooperativa de Ensino Superior, CRL |
| Idioma: | inglês |
| Origem: | Egas Moniz - Cooperativa de Ensino Superior, CRL |
Registos relacionados
category Cohesiveness of powdered co-amorphous Olanzapine and impact on tablet production
por: Costa, Nuno F. da
Publicado em: (2021)
por: Costa, Nuno F. da
Publicado em: (2021)
groups Assessment of the stability of co-amorphous Olanzapine in tablets
por: Costa, Nuno F. da
Publicado em: (2019)
por: Costa, Nuno F. da
Publicado em: (2019)
groups Assessment of the stability of co-amorphous Olanzapine in tablets
por: Costa, Nuno F. da
Publicado em: (2019)
por: Costa, Nuno F. da
Publicado em: (2019)
groups Co-amorphization of olanzapine for solubility enhancement
por: Costa, Nuno F. da
Publicado em: (2018)
por: Costa, Nuno F. da
Publicado em: (2018)
groups Development of an at-line method to monitor the conversion of amorphous into crystalline olanzapine, in dry blends or wet masses
por: Costa, Nuno F. da
Publicado em: (2019)
por: Costa, Nuno F. da
Publicado em: (2019)
groups Production of co-amorphous systems with olanzapine and indomethacin
por: Bastos, Ana C.
Publicado em: (2018)
por: Bastos, Ana C.
Publicado em: (2018)
groups Production of co-amorphous systems with olanzapine and indomethacin
por: Bastos, Ana C.
Publicado em: (2018)
por: Bastos, Ana C.
Publicado em: (2018)
groups Development of an at-line method to monitor the conversion of amorphous into crystalline Olanzapine, in dry blends of wet masses
por: Costa, Nuno F. da
Publicado em: (2019)
por: Costa, Nuno F. da
Publicado em: (2019)
groups Co-amorphization of olanzapine and saccharin : a pathway to increase solubility in water
por: Costa, N. F. da
Publicado em: (2018)
por: Costa, N. F. da
Publicado em: (2018)
article In situ co-amorphization of Olanzapine in the matrix and on the coat of pellets
por: Costa, Nuno F. da
Publicado em: (2022)
por: Costa, Nuno F. da
Publicado em: (2022)
groups Characterization and stability of co-amorphous systems containing Olanzapine and sulfonic acids
por: Santos, Inês A.
Publicado em: (2019)
por: Santos, Inês A.
Publicado em: (2019)
groups Co-formability, solubility enhancement and stability of Olanzapine co-amorphous systems produced with different co-formers
por: Bastos, Ana C.
Publicado em: (2019)
por: Bastos, Ana C.
Publicado em: (2019)
category Downstream processing of co-amorphous olanzapine
por: Costa, Nuno F. da
Publicado em: (2021)
por: Costa, Nuno F. da
Publicado em: (2021)
category Downstream processing of co-amorphous olanzapine
por: Costa, Nuno F. da
Publicado em: (2021)
por: Costa, Nuno F. da
Publicado em: (2021)
groups Co-formability, solubility enhancement and stability of Olanzapine co-amorphous systems produced with different co-formers
por: Bastos, Ana C.
Publicado em: (2019)
por: Bastos, Ana C.
Publicado em: (2019)
groups Comparison of the amorphization ability of two polymorphic forms of Olanzapine
por: Chendo, Catarina
Publicado em: (2019)
por: Chendo, Catarina
Publicado em: (2019)
groups Comparison of the amorphization ability of two polymorphic forms of olanzapine
por: Chendo, Catarina
Publicado em: (2019)
por: Chendo, Catarina
Publicado em: (2019)
groups Comparison of the co-amorphization ability of Olanzapine with amino, carboxylic and sulfonic acids
por: Bastos, Ana C.
Publicado em: (2019)
por: Bastos, Ana C.
Publicado em: (2019)
groups In-situ co-amorphization of olanzapine in pellets
por: Azevedo, Raquel
Publicado em: (2022)
por: Azevedo, Raquel
Publicado em: (2022)
article Amorphous and co-amorphous Olanzapine stability in formulations intended for wet granulation and pelletization
por: Costa, Nuno F. da
Publicado em: (2022)
por: Costa, Nuno F. da
Publicado em: (2022)
article Sulfonic acid derivatives in the production of stable co-amorphous systems for solubility enhancement
por: Costa, Nuno F. da
Publicado em: (2022)
por: Costa, Nuno F. da
Publicado em: (2022)
school In-situ production of co-amorphous drug-based entities for solubility enhancement
por: Azevedo, Raquel Filipa da Silva
Publicado em: (2022)
por: Azevedo, Raquel Filipa da Silva
Publicado em: (2022)
groups Comparison of the co-amorphization ability of Olanzapine with amino, carboxylic and sulfonic acids
por: Bastos, Ana C.
Publicado em: (2019)
por: Bastos, Ana C.
Publicado em: (2019)
groups Production of co-amorphous materials with therapeutic activity
por: Bastos, Ana C.
Publicado em: (2017)
por: Bastos, Ana C.
Publicado em: (2017)
school Assessment of the stability of drugs in the amorphous and co-amorphous form in extrudates, pellets and tablets designed to circumvent drugs’ poor water solubility
por: Costa, Nuno Gonçalo Ferreira da
Publicado em: (2023)
por: Costa, Nuno Gonçalo Ferreira da
Publicado em: (2023)
school Co-precipitation as an amorphization process for “Brick Dust” APIs
por: Almeida, Pedro Miguel de Oliveira
Publicado em: (2024)
por: Almeida, Pedro Miguel de Oliveira
Publicado em: (2024)
school Understanding the degradation of olanzapine by an oxidative pathway in samples with different fractions of amorphous and crystalline contents
por: Barbosa, Matilde Carvalho
Publicado em: (2022)
por: Barbosa, Matilde Carvalho
Publicado em: (2022)
groups Drug-excipient and drug-drug mixtures : a pathway for the production of co-amorphous entities
por: Costa, Nuno F. da
Publicado em: (2018)
por: Costa, Nuno F. da
Publicado em: (2018)
groups Drug-excipient and drug-drug mixtures: a pathway for the production of co-amorphous entities
por: Costa, Nuno F. da
Publicado em: (2018)
por: Costa, Nuno F. da
Publicado em: (2018)
article Co-amorphous formulations of furosemide with arginine and p-glycoprotein inhibitor drugs
por: Ruponen, Marika
Publicado em: (2021)
por: Ruponen, Marika
Publicado em: (2021)
school A study on the stability of olanzapine polymorphs
por: Silva, Sara Alexandra Marques Gonçalves Botto da
Publicado em: (2014)
por: Silva, Sara Alexandra Marques Gonçalves Botto da
Publicado em: (2014)
category Olanzapine: challenges in toxicological results interpretation
por: Costa Lopes, Miguel
Publicado em: (2017)
por: Costa Lopes, Miguel
Publicado em: (2017)
article Olanzapine-Induced Fever
por: Ferreira, TF
Publicado em: (2019)
por: Ferreira, TF
Publicado em: (2019)
article Anomalous Nernst Effect in flexible co-based amorphous ribbons
por: Correa, Marcio A.
Publicado em: (2023)
por: Correa, Marcio A.
Publicado em: (2023)
groups Measurement of photo capacitance in amorphous silicon photodiodes
por: Gonçalves, Dora
Publicado em: (2013)
por: Gonçalves, Dora
Publicado em: (2013)
school Crystal engineering and thermodynamics of co-amorphous solid phases of pharmaceutical interest
por: Silva, Joana Filipa Carvalho da
Publicado em: (2025)
por: Silva, Joana Filipa Carvalho da
Publicado em: (2025)
article Olanzapine-Induced Hyperprolactinemia: Two Case Reports.
por: Barata, P
Publicado em: (2019)
por: Barata, P
Publicado em: (2019)
article Amorphous nasal powder advanced performance : in vitro/ex vivo studies and correlation with in vivo pharmacokinetics
por: Henriques, Patrícia
Publicado em: (2023)
por: Henriques, Patrícia
Publicado em: (2023)
article Synthesis and characterization of amorphous poly(ethylene oxide)/poly(trimethylene carbonate) polymer blend electrolytes
por: Rodrigues, Luísa
Publicado em: (2012)
por: Rodrigues, Luísa
Publicado em: (2012)
category Solid state conversion of olanzapine during tableting
por: Costa, Nuno F. da
Publicado em: (2021)
por: Costa, Nuno F. da
Publicado em: (2021)
Registos relacionados
-
category Cohesiveness of powdered co-amorphous Olanzapine and impact on tablet production
por: Costa, Nuno F. da
Publicado em: (2021) -
groups Assessment of the stability of co-amorphous Olanzapine in tablets
por: Costa, Nuno F. da
Publicado em: (2019) -
groups Assessment of the stability of co-amorphous Olanzapine in tablets
por: Costa, Nuno F. da
Publicado em: (2019) -
groups Co-amorphization of olanzapine for solubility enhancement
por: Costa, Nuno F. da
Publicado em: (2018) -
groups Development of an at-line method to monitor the conversion of amorphous into crystalline olanzapine, in dry blends or wet masses
por: Costa, Nuno F. da
Publicado em: (2019)